Connection

Elizabeth Garrett-Mayer to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Antibodies, Monoclonal, Humanized.
Elizabeth Garrett-Mayer
Connection Strength
0.049
Antibodies, Monoclonal, Humanized
  1. A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer Immunol Res. 2014 Oct; 2(10):949-61.
    View in: PubMed
    Score: 0.027
  2. Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 2012; 82(2):67-74.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.